← Every company
Maravai LifeSciences Holdings Inc SEC Filings
What Maravai LifeSciences Holdings Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
MRVI overview →Filings on file
80
since Oct 29, 2020
Warning signs
3
latest Jul 18, 2025
Last results
Aug 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 7, 2026 | Quarterly report 10-Q | Read ↗ |
| Aug 6, 2026 | Results announced 8-K | Read ↗ |
| Jun 3, 2026 | Material agreementNew debt 8-K | Read ↗ |
| May 29, 2026 | Shareholder vote 8-K | Read ↗ |
| May 8, 2026 | Quarterly report 10-Q | Read ↗ |
| May 7, 2026 | Results announced 8-K | Read ↗ |
| Feb 26, 2026 | Annual report 10-K | Read ↗ |
| Feb 25, 2026 | Results announced 8-K | Read ↗ |
| Nov 7, 2025 | Quarterly report 10-Q | Read ↗ |
| Nov 6, 2025 | Results announced 8-K | Read ↗ |
| Oct 27, 2025 | Executive or director change 8-K | Read ↗ |
| Aug 11, 2025 | Quarterly report 10-Q | Read ↗ |
| Aug 11, 2025 | Executive or director changeResults announcedRestructuring 8-K | Read ↗ |
| Jul 18, 2025 | Auditor change 8-K | Read ↗ |
| Jun 25, 2025 | Executive or director change 8-K | Read ↗ |
| Jun 9, 2025 | Executive or director change 8-K | Read ↗ |
| May 28, 2025 | Shareholder vote 8-K | Read ↗ |
| May 12, 2025 | Quarterly report 10-Q | Read ↗ |
| May 12, 2025 | Results announced 8-K | Read ↗ |
| Mar 18, 2025 | Annual report 10-K | Read ↗ |
| Mar 18, 2025 | Earlier accounts withdrawnResults announced 8-K | Read ↗ |
| Mar 4, 2025 | Late filing notice NT 10-K | Read ↗ |
| Feb 25, 2025 | Results announced 8-K | Read ↗ |
| Jan 8, 2025 | Executive or director changeResults announced 8-K | Read ↗ |
| Dec 5, 2024 | Executive or director change 8-K | Read ↗ |
| Nov 12, 2024 | Quarterly report 10-Q | Read ↗ |
| Nov 7, 2024 | Results announced 8-K | Read ↗ |
| Sep 12, 2024 | Material agreement 8-K | Read ↗ |
| Aug 8, 2024 | Quarterly report 10-Q | Read ↗ |
| Aug 7, 2024 | Results announced 8-K | Read ↗ |
| Jul 29, 2024 | Executive or director change 8-K | Read ↗ |
| Jun 12, 2024 | Executive or director change 8-K | Read ↗ |
| May 28, 2024 | Shareholder vote 8-K | Read ↗ |
| May 9, 2024 | Quarterly report 10-Q | Read ↗ |
| May 8, 2024 | Results announced 8-K | Read ↗ |
| Feb 29, 2024 | Annual report 10-K | Read ↗ |
| Feb 22, 2024 | Results announced 8-K | Read ↗ |
| Nov 8, 2023 | Quarterly report 10-Q | Read ↗ |
| Nov 7, 2023 | Results announced 8-K | Read ↗ |
| Aug 8, 2023 | Quarterly report 10-Q | Read ↗ |
| Aug 7, 2023 | Results announced 8-K | Read ↗ |
| Jul 27, 2023 | Executive or director change 8-K | Read ↗ |
| Jul 20, 2023 | Executive or director change 8-K | Read ↗ |
| May 22, 2023 | Shareholder vote 8-K | Read ↗ |
| May 9, 2023 | Quarterly report 10-Q | Read ↗ |
| May 8, 2023 | Results announced 8-K | Read ↗ |
| Mar 13, 2023 | Executive or director change 8-K | Read ↗ |
| Feb 28, 2023 | Annual report 10-K | Read ↗ |
| Feb 22, 2023 | Results announced 8-K | Read ↗ |
| Dec 1, 2022 | Executive or director change 8-K | Read ↗ |
| Nov 4, 2022 | Quarterly report 10-Q | Read ↗ |
| Nov 2, 2022 | Results announced 8-K | Read ↗ |
| Oct 19, 2022 | Executive or director change 8-K | Read ↗ |
| Oct 3, 2022 | Executive or director change 8-K | Read ↗ |
| Aug 5, 2022 | Quarterly report 10-Q | Read ↗ |
| Aug 4, 2022 | Results announced 8-K | Read ↗ |
| May 16, 2022 | Shareholder vote 8-K | Read ↗ |
| May 6, 2022 | Quarterly report 10-Q | Read ↗ |
| May 5, 2022 | Results announced 8-K | Read ↗ |
| Mar 1, 2022 | Annual report 10-K | Read ↗ |
| Feb 23, 2022 | Results announced 8-K | Read ↗ |
| Jan 20, 2022 | Material agreement 8-K | Read ↗ |
| Nov 15, 2021 | Quarterly report 10-Q | Read ↗ |
| Nov 10, 2021 | Results announced 8-K | Read ↗ |
| Sep 13, 2021 | Share offering 424B4 | Read ↗ |
| Sep 7, 2021 | Share offering S-1 | Read ↗ |
| Sep 3, 2021 | Acquisition or sale completedMaterial agreement 8-K | Read ↗ |
| Aug 11, 2021 | Quarterly report 10-Q | Read ↗ |
| Aug 10, 2021 | Results announcedMaterial agreement 8-K | Read ↗ |
| May 20, 2021 | Executive or director changeShareholder vote 8-K | Read ↗ |
| May 12, 2021 | Quarterly report 10-Q | Read ↗ |
| May 10, 2021 | Results announced 8-K | Read ↗ |
| Apr 9, 2021 | Share offering 424B4 | Read ↗ |
| Apr 5, 2021 | Results announced 8-K | Read ↗ |
| Apr 5, 2021 | Share offering S-1 | Read ↗ |
| Mar 22, 2021 | Annual report 10-K | Read ↗ |
| Mar 2, 2021 | Results announced 8-K | Read ↗ |
| Nov 25, 2020 | Executive or director changeMaterial agreementUnregistered share sale 8-K | Read ↗ |
| Nov 23, 2020 | Share offering 424B4 | Read ↗ |
| Oct 29, 2020 | Share offering S-1 | Read ↗ |
Source: Maravai LifeSciences Holdings Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.